"Excellent new research in the area of Antibody Engineering. Very innovative. Excellent list of speakers. Beautifully organized meeting."
Eugene Zhukovsky, Affimed Gmbh
Do you need to meet mAb, ADC, multi format and next generation technology decision makers, influencers and end users?
If so we have a room full from large and mid cap pharma, large and SME biotech, academic and research institutes, government bodies and regulatory boards.
"Highly focussed meeting with most participants being open to sharing experiences and data"
Steve Megit, Immunocore Ltd
"Very good opportunity to meet new and existing contacts"
Tatyana Hrechdakian, Quality Assistance
"The best global antibody meeting"
Alain Beck, Centre d’Immunologie Pierre Fabre
For more networking opportunities:
At last years World Drug Safety Congress Europe 2014 event, Anca Miclea, Senior Specialist Medical Safety and Epidemiology Global Pharmacovigilance, Abbott laboratories, gave the presentation ...
The post Safety, pharmacoepidemiology and research in practice: assessment of causation appeared first on Total Biopharma.
Remsima Case Study: The importance of ADCC in assessing clinically relevant differences Authors: Dr. Daniel Galbraith, Chief Scientific Officer and Andy Upsall, Director of Technical ...
The post Biosimilars have caused a revolution in the development of biologic drugs appeared first on Total Biopharma.
Innovation and strategy for pharmaceutical, biotech and R&D